Literature DB >> 761980

Malignant pericardial effusions.

P D Doherty, E C Sweeney, C M Oakley.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 761980     DOI: 10.1007/bf02938039

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  19 in total

1.  MESOTHELIOMA IN CHILDREN.

Authors:  S L KAUFFMAN; A P STOUT
Journal:  Cancer       Date:  1964-04       Impact factor: 6.860

2.  AN UNUSUAL CASE OF SACROCOCCYGEAL MESONEPHROMA (SCHILLER).

Authors:  N R RAO; M SRINIVASAN; G D VELIATH
Journal:  Cancer       Date:  1964-12       Impact factor: 6.860

3.  Primary sarcoma of the pericardium.

Authors:  R P TOWERS; R MULCAHY
Journal:  Br Heart J       Date:  1962-09

4.  Angiosarcoma of pericardium. Problems in diagnosis and management.

Authors:  P A Poole-Wilson; A Farnsworth; M V Braimbridge; H Pambakian
Journal:  Br Heart J       Date:  1976-03

5.  Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor).

Authors:  G Teilum; R Albrechtsen; B Norgaard-Pedersen
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-07

6.  Alpha-fetoprotein. Occurrence in germinal cell and liver malignancies.

Authors:  J B Smith; R T O'Neill
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

7.  Primary pericardial mesothelioma: report of two cases and review of the literature.

Authors:  A L Sytman; R N MacAlpin
Journal:  Am Heart J       Date:  1971-06       Impact factor: 4.749

8.  Extragondal endodermal sinus tumours originating in the region of the pineal gland.

Authors:  J Bestle
Journal:  Acta Pathol Microbiol Scand       Date:  1968

9.  A case of mesothelioma pericardii.

Authors:  E L Cardozo; J F Saltet
Journal:  Acta Med Scand       Date:  1965-09

10.  Immune enhancement of the tumorigenicity of hamster brain tumor cells persistently infected with measles virus.

Authors:  J F Evermann; T Burnstein
Journal:  Int J Cancer       Date:  1975-11-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.